These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 30190127

  • 1. Association of NPSR1 rs324981 polymorphism and treatment response to antidepressants in Chinese Han population with generalized anxiety disorder.
    He Q, Shen Z, Ren L, Wang X, Qian M, Zhu J, Shen X.
    Biochem Biophys Res Commun; 2018 Sep 26; 504(1):137-142. PubMed ID: 30190127
    [Abstract] [Full Text] [Related]

  • 2. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
    Bose A, Korotzer A, Gommoll C, Li D.
    Depress Anxiety; 2008 Sep 26; 25(10):854-61. PubMed ID: 18050245
    [Abstract] [Full Text] [Related]

  • 3. The roles of brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) in predicting treatment remission in a Chinese Han population with generalized anxiety disorder.
    Shen Z, Zhu J, Yuan Y, Ren L, Qian M, Lin M, Cai M, Zhang Z, Shen X.
    Psychiatry Res; 2019 Jan 26; 271():319-324. PubMed ID: 30529313
    [Abstract] [Full Text] [Related]

  • 4. Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder.
    Lohoff FW, Aquino TD, Narasimhan S, Multani PK, Etemad B, Rickels K.
    Pharmacogenomics J; 2013 Feb 26; 13(1):21-6. PubMed ID: 22006095
    [Abstract] [Full Text] [Related]

  • 5. Association Analysis of the Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Gender with Efficacy of Antidepressants in the Chinese Han Population with Generalized Anxiety Disorder.
    Lin M, Zhu J, Yuan Y, Ren L, Qian M, Shen Z, Shao Y, Shen X.
    Genet Test Mol Biomarkers; 2018 Mar 26; 22(3):199-206. PubMed ID: 29446659
    [Abstract] [Full Text] [Related]

  • 6. Genome-wide association study of treatment response to venlafaxine XR in generalized anxiety disorder.
    Jung J, Tawa EA, Muench C, Rosen AD, Rickels K, Lohoff FW.
    Psychiatry Res; 2017 Aug 26; 254():8-11. PubMed ID: 28437668
    [Abstract] [Full Text] [Related]

  • 7. The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) influences age at onset of obsessive-compulsive disorder.
    Lennertz L, Franke PE, Grabe HJ, Rampacher F, Schulze-Rauschenbach S, Guttenthaler V, Ruhrmann S, Pukrop R, Klosterkötter J, Falkai P, Maier W, Wagner M, Mössner R.
    Int J Neuropsychopharmacol; 2013 Oct 26; 16(9):1951-8. PubMed ID: 23680103
    [Abstract] [Full Text] [Related]

  • 8. Higher baseline serum adiponectin predicts better treatment remission in patients with generalized anxiety disorder treated with escitalopram.
    Shen Z, Wang F, Cui L, Ren L, Hong X, Yuan Y, Shen X.
    Ann Palliat Med; 2021 Jul 26; 10(7):7634-7643. PubMed ID: 34353051
    [Abstract] [Full Text] [Related]

  • 9. Interaction of the neuropeptide S receptor gene Asn¹⁰⁷Ile variant and environment: contribution to affective and anxiety disorders, and suicidal behaviour.
    Laas K, Reif A, Akkermann K, Kiive E, Domschke K, Lesch KP, Veidebaum T, Harro J.
    Int J Neuropsychopharmacol; 2014 Apr 26; 17(4):541-52. PubMed ID: 24331455
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Investigating the Contribution of NPSR1, IL-6 and BDNF Polymorphisms to Depressive and Anxiety Symptoms in Hemodialysis Patients.
    Alshogran OY, Al-Eitan LN, Altawalbeh SM, Khalil AA, Alqudah MAY, Oweis AO, Aman HA, Alhawari HH.
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug 30; 94():109657. PubMed ID: 31132388
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.
    Demyttenaere K, Andersen HF, Reines EH.
    Int Clin Psychopharmacol; 2008 Sep 30; 23(5):276-86. PubMed ID: 18703937
    [Abstract] [Full Text] [Related]

  • 15. Neuropeptide S receptor gene Asn107 polymorphism in obese male individuals in Pakistan.
    Ahmad A, Almsned F, Ghazal P, Ahmed MW, Jafri MS, Bokhari H.
    PLoS One; 2020 Sep 30; 15(12):e0243205. PubMed ID: 33332443
    [Abstract] [Full Text] [Related]

  • 16. Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein.
    O'Connell CP, Goldstein-Piekarski AN, Nemeroff CB, Schatzberg AF, Debattista C, Carrillo-Roa T, Binder EB, Dunlop BW, Craighead WE, Mayberg HS, Williams LM.
    Am J Psychiatry; 2018 Mar 01; 175(3):251-261. PubMed ID: 29241359
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A functional NPSR1 gene variant and environment shape personality and impulsive action: a longitudinal study.
    Laas K, Reif A, Kiive E, Domschke K, Lesch KP, Veidebaum T, Harro J.
    J Psychopharmacol; 2014 Mar 01; 28(3):227-36. PubMed ID: 23325374
    [Abstract] [Full Text] [Related]

  • 20. Association of Neuropeptide S Receptor 1 and Glutamate Decarboxylase 1 Gene Polymorphisms with Posttraumatic Stress Disorder.
    Haxhibeqiri S, Haxhibeqiri V, Agani F, Goci Uka A, Hoxha B, Dzubur Kulenovic A, Kučukalić A, Avdibegović E, Sinanović O, Babic D, Jakovljevic M, Kučukalić S, Bravo Mehmedbašić A, Kravić N, Muminović-Umihanić M, Babić R, Pavlović M, Jakšić N, Aukst Margetić B, Rudan D, Ferić Bojić E, Marjanović D, Ziegler C, Wolf C, Warrings B, Domschke K, Deckert J.
    Psychiatr Danub; 2019 Jun 01; 31(2):249-255. PubMed ID: 31291233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.